In silico study on Penicillin derivatives and Cephalosporins for upper respiratory tract bacterial pathogens

Area of Science:

• * Microbiology and Medicinal Chemistry
• * Bacterial Pathogenesis and Drug Discovery

Background:

• * Upper respiratory tract infections (URTIs) are common bacterial infections caused by pathogens like Streptococcus pneumoniae.
• * Traditional treatments involve β-lactam antibiotics, but bacterial resistance is a growing concern.
• * Penicillin-binding proteins (PBPs) are crucial for bacterial cell wall synthesis and are targets for β-lactam antibiotics.

Purpose of the Study:

• * To virtually compare new-generation antibiotics and penicillin derivatives for treating URTIs.
• * To identify potent molecules for further drug development against URTI-causing bacteria.
• * To investigate the interaction of novel antibiotics with bacterial PBPs.

Main Methods:

• * 3-Dimensional (3D) molecular interaction studies were performed.
• * Interactions were analyzed between selected antibiotics (Lactivicin, Cefuroxime, Cefadroxil, Ceftaroline, Ceftobiprole, penicillin derivatives) and PBPs of key URTI pathogens.
• * Computational methods were used to assess binding affinities and interaction patterns.

Main Results:

• * The study conducted virtual comparisons of novel antibiotics and penicillin derivatives against bacterial PBPs.
• * Interaction studies provided insights into the binding capabilities of these molecules.
• * Specific new-generation antibiotics showed potential for inhibiting PBP action.

Conclusions:

• * New generation antibiotics exhibit potential for overcoming β-lactam resistance in URTI pathogens.
• * The study suggests specific molecules for further modification to enhance URTI treatment efficacy.
• * Further research is warranted to develop more effective drugs against resistant bacterial infections.